https://pipelinereview.com/Harpoon-Therapeutics-Presents-Interim-Phase-1-Data-from-an-Ongoing-Dose-Escalation-Trial-for-the-PSMA-targeting-TriTAC-HPN424-at-the-ASCO20-Virtual-Scientific-Program/